Access cutting-edge tuberculosis infection treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.
Access tuberculosis infection specialists in Washington Dc at no cost
This study follows strict safety protocols and ethical guidelines
All study-related tuberculosis infection treatment provided free
The purpose of this research is to find out if a single dose of pre-travel vaccination with BCG can lessen tuberculosis (TB) infection by producing an immune response when given to adults traveling to countries with a high burden of TB. BCG will be compared with a placebo (an inactive vaccine). BCG (Japan) is used globally but is not approved for use in the United States, therefore it is considered experimental. Participants choosing to take part in this research study, will be randomly assigned
Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine
Check if you qualify for this tuberculosis infection clinical trial in Washington Dc, DC
If you're searching for tuberculosis infection treatment options in Washington Dc, DC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced tuberculosis infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.